Sociedad Americana de Hirudoterapia

Impact of postoperative complications on patient-reported outcomes in deep inferior epigastric perforator flap breast reconstruction.

Research article published in Breast cancer (Tokyo, Japan) (2025)

Última actualización: 18 de junio de 2026Revisado por: ASH Editorial Board
Artículo de investigación — revisión de evidenciaReferencia del artículo
Evidence: Research reportEnsayos clínicosGuo et al. · Breast cancer (Tokyo, Japan), 2025

Abstract

OBJECTIVE: This study aims to investigate the factors that influence the occurrence of complications following deep inferior epigastric perforator (DIEP) flap breast reconstruction, and to determine whether these complications have an impact on the patient's quality of life in China. METHODS: We collected clinical data from patients who underwent DIEP flap breast reconstruction at the Department of Breast, Affiliated Cancer Hospital of Zhengzhou University between December 2019 and December 2023. We analyzed the incidence of postoperative complications and their relationship with patient clinical data and surgical parameters. We also used the BREAST-Q 2.0 Chinese version scale to assess the impact of postoperative complications on patient-reported outcomes. RESULTS: A total of 109 patients underwent DIEP flap breast reconstruction, including 91 stage I reconstructions and 18 stage II reconstructions. Postoperative complications occurred in 26 cases (23.9%), including flap complications in 13 cases (11.9%) and abdominal donor-site complications in 13 cases (11.9%). Univariate and multivariate analyses showed that the overall incidence of complications was associated with high BMI and early surgery (P < 0.05). Flap complications were associated with high BMI, early surgery, and the use of internal mammary vascular branches as recipient vessels (P < 0.05). Abdominal complications were associated with previous abdominal surgery scars (P < 0.05). Approximately 20% of patients did not complete the BREAST-Q questionnaires (including the two patients who experienced total flap loss). BREAST-Q scores showed no significant differences between the surgical complication group and the no-complication group in terms of breast satisfaction, mental health, physical health-chest, physical health-abdomen, satisfaction with abdomen, sexual health, etc. (P > 0.05). CONCLUSION: Patients who underwent DIEP flap breast reconstruction revealed that high BMI, neoadjuvant therapy, and abdominal incision scars may influence postoperative complications. The limited follow-up data indicated that postoperative complications did not impact patient-reported outcomes.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsHumansFemaleMammaplastyPerforator FlapPostoperative ComplicationsMiddle AgedPatient Reported Outcome MeasuresBreast NeoplasmsQuality of LifeAdultChinaEpigastric Arteries

Resumen

This study aims to investigate the factors that influence the occurrence of complications following deep inferior epigastric perforator (DIEP) flap breast reconstruction, and to determine whether these complications have an impact on the patient's quality of life in China. We collected clinical...

Por qué esto importa para la hirudoterapia

Este estudio analizó 109 reconstrucciones mamarias con colgajo DIEP en un hospital oncológico chino, informando de una tasa global de complicaciones del 23,9% (complicaciones del colgajo y del sitio donante del 11,9% cada una) asociada a un IMC elevado, experiencia quirúrgica temprana y cicatrices abdominales previas; los resultados reportados por las pacientes mediante BREAST-Q no mostraron diferencias significativas entre los grupos con y sin complicaciones. Si bien las complicaciones del colgajo representan escenarios en los que la terapia con sanguijuelas podría emplearse teóricamente para la congestión venosa, este estudio no menciona ni evalúa el uso de sanguijuelas. El trabajo ofrece antecedentes indirectos sobre los patrones de complicaciones en la reconstrucción con colgajos, pero no aporta evidencia directa relevante para la práctica de la hirudoterapia.

Citación

Impact of postoperative complications on patient-reported outcomes in deep inferior epigastric perforator flap breast reconstruction.

Guo et al. · Breast cancer (Tokyo, Japan), 2025

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 28, 2026 · Última actualización del sitio: 18 de junio de 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.